This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Tiffany Underwood is one of L+A’s 10 Estheticians To Watch! She’s an award-winning esthetician, she’s a medical spa owner, and she founded a non-profit for cancer patients! She’s also a huge fan of Celluma LED Light Therapy devices and uses them in 99% of her treatments! Thanks to Celluma LED Light Therapy for sponsoring this content so that L+A can share Tiffany’s story with our community.
The skin is the largest organ in the human body and is made up of several layers that work together to protect the body from harmful environmental factors and regulate internal temperature. The three main … Continue reading How the skin works by Rena Levi The post How the skin works by Rena Levi appeared first on NASNPRO - National Aesthetic Spa Network.
In case you missed it, this week had news about the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, the FDA-approved expanded use of tirbanibulin for actinic keratosis, FDA and EMA support of continuing MoonLake's phase 3 trial of sonelokimab for PsA, and more.
Learn how to open a gym with our step-by-step guide. From finding your niche and funding to building a team, turn your passion into a successful business.
Spinach and Strawberry Salad This Spinach and Strawberry Salad is a delightful blend of fresh, sweet, and tangy flavours. Perfect for a quick lunch or a light dinner, it’s as beautiful as it is nutritious. Enjoy it on its own or pair it with your favourite protein source, like grilled chicken or tofu for a vegan option. Ingredients • 4 cups (960 ml) fresh spinach leaves • 1 cup (240 ml) strawberries, sliced • 1/4 cup (60 ml) red onion, thinly sliced • 1/4 cup (60 ml) slivered almonds • 1/4 cup (
Although acne is common for most people to experience in their lifetime, it is important to individualize treatment and provide appropriate care when working with a diverse patient base.
EWG recently put out their 2024 Sunscreen Guide. Just in time to scare consumers about their sunscreen choices for the summer. Should you as a consumer be worried? Does the EWG actually want to make sun protection in the USA safer? Or are they putting these guides out as a fear marketing campaign to promote the EWG seal program (which makes them money)?
Learn how to open a gym with our step-by-step guide. From finding your niche and funding to building a team, turn your passion into a successful business.
Jonathan Silverberg, MD, PhD, MPH, Director of Clinical Research at The George Washington University School of Medicine and Health Sciences in Washington, DC, breaks down the new data from LEVEL-UP, a head-to-head study evaluating upadacitinib (Rinvoq, AbbVie) vs. dupilumab (Dupixent, Sanofi & Regeneron) for the treatment of adolescents and adults with moderate to severe atopic dermatitis who had inadequate response to systemic therapy or when systemic therapies were not advised.
Learn how to open a gym with our step-by-step guide. From finding your niche and funding to building a team, turn your passion into a successful business.
The U.S. Food and Drug Administration (FDA) has cleared InnoCare Pharma’s investigational new drug application (IND) for ICP-332, a tyrosine kinase 2 (TYK2) inhibitor that’s being studied in moderate to severe atopic dermatitis (AD). Currently, no TYK2 inhibitors have obtained marketing approval for the treatment of AD. ICP-332 achieved multiple efficacy endpoints in the China Phase II study of patients with moderate-to-severe AD and demonstrated an “outstanding” and safety profile.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content